US Patent 11414416 Compounds and uses thereof
Patent 11414416 was granted and assigned to Foghorn Therapeutics on August, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11414416 Compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
